ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma.

Omid Hamid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.